Imperial Capital Downgrades Stericycle (SRCL) to Underperform

Go back to Imperial Capital Downgrades Stericycle (SRCL) to Underperform

Stericycle (SRCL) Cutting Price Target on Reduced Guidance - Jefferies

July 29, 2016 8:41 AM EDT

Jefferies analyst, Sean Dodge, reiterated his Buy rating on shares of Stericycle (NASDAQ: SRCL) after 2Q EPS was in line, but growth in both core and non-core businesses decelerated. Guidance for '16 was lowered again to reflect this. Management is taking aggressive steps to... More

Stericycle (SRCL) Reports In-Line Q2 EPS, Revenue Light

July 28, 2016 4:18 PM EDT

Stericycle (NASDAQ: SRCL) reported Q2 EPS of $1.18, in-line with the analyst estimate of $1.18. Revenue for the quarter came in at $891.6 million versus the consensus estimate of $912.79 million.

For earnings history and earnings-related data on Stericycle (SRCL) click here.

... More